Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tyce Bruns"'
Autor:
Alejandro Parrales, Peter McDonald, Megan Ottomeyer, Anuradha Roy, Frank J Shoenen, Melinda Broward, Tyce Bruns, Douglas H Thamm, Scott J Weir, Kathleen A Neville, Tomoo Iwakuma, Joy M Fulbright
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194224 (2018)
BACKGROUND:Osteosarcoma is an orphan disease for which little improvement in survival has been made since the late 1980s. New drug discovery for orphan diseases is limited by the cost and time it takes to develop new drugs. Repurposing already approv
Externí odkaz:
https://doaj.org/article/fcfb7274e7014e86bedf45880a5e58f5
Autor:
Joseph P. McGuirk, Sunil H Abhyankar, Trishna Goswami, Rupal Soder, Mariska ter Haak, Tyce Bruns, Samantha Langford Youngblood, Lawrence S. Lamb
Publikováno v:
Blood. 140:7464-7465
Autor:
Frank J. Schoenen, Mitchell W. Braun, Scott Weir, Alejandro Parrales, Joy M. Fulbright, Melinda Broward, Tyce Bruns, Douglas H. Thamm, Peter R. McDonald, Tomoo Iwakuma, Kathleen A. Neville, Fred Meyer, Shrikant Anant, Jenna Wang, Anuradha Roy, Katherine Chastain, Steve Rogers, Dan A. Dixon
Publikováno v:
Cancer Research. 78:2903-2903
Osteosarcoma is the second-highest cause of cancer-related death in children and adolescents. Despite advances in chemotherapy and surgery, the survival rate for metastatic osteosarcoma remains below 30% for the last three decades. Discovery of new c
Autor:
Tomoo Iwakuma, Megan Ottomeyer, Anuradha Roy, Joy M. Fulbright, Alejandro Parrales, Douglas H. Thamm, Frank J. Shoenen, Scott Weir, Peter R. McDonald, Melinda Broward, Tyce Bruns, Kathleen A. Neville
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194224 (2018)
PLoS ONE
PLoS ONE
Background Osteosarcoma is an orphan disease for which little improvement in survival has been made since the late 1980s. New drug discovery for orphan diseases is limited by the cost and time it takes to develop new drugs. Repurposing already approv